"We view Omidria sales as a means for OMER to fund one of the most exciting biotechnology pipelines in the industry." (4/8/15) Omeros Corp. - The Life Sciences Report Interview with Jason Kolbert More >
"STEM is doing pioneering work in the field of cervical spinal cord Injury and dry age-related macular degeneration." (4/8/15) StemCells Inc. - The Life Sciences Report Interview with Jason Kolbert More >
Subscribe to Streetwise Reports’ Newsletters
Receive weekly insight into today’s investment ideas from leading analysts and experts.
To make sure our emails arrive in your inbox, please add firstname.lastname@example.org to your "safe sender" list. If you are unsure how to whitelist or add someone to your safe senders list, please follow the instructions here.
"INO's idea of using DNA, which is simple to make and cost-effective, to drive the body's natural immune response is just fascinating." (3/25/15) Inovio Pharmaceuticals Inc. - The Life Sciences Report Interview with Jill Wahleithner More >